data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
NovaBay Pharmaceuticals
(AMEX:NBY)
$0.2742
0.0242[9.68%]
At close: Jul 1
$0.2605
-0.0137[-5.00%]
After Hours: 4:27PM EDT
Day High/Low0.25 - 0.29
52 Week High/Low0.17 - 0.77
Open / Close0.26 / 0.26
Float / Outstanding46.7M / 52.6M
Vol / Avg.516.1K / 595.8K
Mkt Cap14.4M
P/E-
50d Avg. Price0.22
Div / Yield-
Payout Ratio-
EPS0
Total Float46.7M

NovaBay Pharmaceuticals (AMEX:NBY), Quotes and News Summary

NovaBay Pharmaceuticals (AMEX: NBY)

Day High/Low0.25 - 0.29
52 Week High/Low0.17 - 0.77
Open / Close0.26 / 0.26
Float / Outstanding46.7M / 52.6M
Vol / Avg.516.1K / 595.8K
Mkt Cap14.4M
P/E-
50d Avg. Price0.22
Div / Yield-
Payout Ratio-
EPS0
Total Float46.7M
Benzinga - Jun 21, 2022, 1:53PM
Benzinga - Jun 9, 2022, 11:49AM
Benzinga - Jun 3, 2022, 11:24AM
Benzinga - May 20, 2022, 9:33AM
Benzinga - May 16, 2022, 10:52AM
Benzinga - May 12, 2022, 4:10PM
Benzinga - May 11, 2022, 10:55AM
Benzinga - May 9, 2022, 6:54AM
Benzinga - May 3, 2022, 1:08PM
Benzinga - May 2, 2022, 11:04AM
Benzinga - Apr 25, 2022, 6:50AM
Benzinga - Apr 19, 2022, 11:55AM
Benzinga - Apr 11, 2022, 3:24PM
Benzinga - Apr 1, 2022, 6:54AM
Benzinga - Mar 29, 2022, 4:12PM
Benzinga - Mar 17, 2022, 1:12PM
load more
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.030-0.050 -0.0200
REV3.260M2.629M-631.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

NovaBay Pharmaceuticals Questions & Answers

Q
How do I buy NovaBay Pharmaceuticals (NBY) stock?
A

You can purchase shares of NovaBay Pharmaceuticals (AMEX: NBY) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are NovaBay Pharmaceuticals's (NBY) competitors?
A

There are no as such competitors for NovaBay Pharmaceuticals.

Q
What is the target price for NovaBay Pharmaceuticals (NBY) stock?
A

The latest price target for NovaBay Pharmaceuticals (AMEX: NBY) was reported by Ascendiant Capital on Friday, May 20, 2022. The analyst firm set a price target for 4.00 expecting NBY to rise to within 12 months (a possible 1358.79% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for NovaBay Pharmaceuticals (NBY)?
A

The stock price for NovaBay Pharmaceuticals (AMEX: NBY) is $0.2742 last updated July 1, 2022, 7:59 PM UTC.

Q
Does NovaBay Pharmaceuticals (NBY) pay a dividend?
A

There are no upcoming dividends for NovaBay Pharmaceuticals.

Q
When is NovaBay Pharmaceuticals (AMEX:NBY) reporting earnings?
A

NovaBay Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is NovaBay Pharmaceuticals (NBY) going to split?
A

There is no upcoming split for NovaBay Pharmaceuticals.

Q
What sector and industry does NovaBay Pharmaceuticals (NBY) operate in?
A

NovaBay Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the AMEX.